Home › Orexigen: Contrave Sales Set New Record- Still Not Enough To Satisfy The Street
 

Keywords :   


Orexigen: Contrave Sales Set New Record- Still Not Enough To Satisfy The Street

2015-09-15 03:32:09| Biotech - Topix.net

Orerxigen understand first hand what it is like to be the leader in a sector and still get the stock beat up. The main reason for that is that despite outpacing the competition in the branded anti-obesity sector, sales are much lower than what is needed to deliver the level of revenue that will impress the street.

Tags: to the set sales

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Eastern North Pacific Tropical Weather Outlook
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
More »